Science Explorer Back to mapMap

Most cited papers from Pelago Bioscience (Sweden)

What are the most cited papers from Pelago Bioscience (Sweden)?

The most cited paper from Pelago Bioscience (Sweden) is "The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies" (Daniel Martinez Molina, Pär Nordlund, 2015), with 313 citations. Next come "Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6" (141) and "ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery" (85).

Showing 50 of 51 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies Daniel Martinez Molina, Pär Nordlund · The Annual Review of Pharmacology and Toxicology ReviewOpen access 13 Nov 2015 313
2 Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6 William McCoull et al. · ACS Chemical Biology Open access 17 Oct 2018 141
3 ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery Amir Ata Saei, Christian Michel Beusch, Alexey L. Chernobrovkin et al. · Nature Communications Open access 16 Dec 2019 85
4 Cellularly active N-hydroxyurea FEN1 inhibitors block substrate entry to the active site Jack C. Exell, Mark Jason Thompson, L. David Finger et al. · Nature Chemical Biology Open access 15 Aug 2016 79
5 Current Advances in CETSA Tuomas Aleksi Tolvanen · Frontiers in Molecular Biosciences Open access 9 Jun 2022 75
6 Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib Nusayba Ali Bagegni, Shana N. Thomas, Ning Liu et al. · Breast Cancer Research Open access 21 Nov 2017 74
7 System-wide identification and prioritization of enzyme substrates by thermal analysis Amir Ata Saei, Christian Michel Beusch, Pierre Sabatier et al. · Nature Communications Open access 26 Feb 2021 73
8 Selective release of miRNAs via extracellular vesicles is associated with house‐dust mite allergen‐induced airway inflammation Yasuhiro Gon, S. Maruoka, Takuya Inoue et al. · Clinical & Experimental Allergy 31 Aug 2017 67
9 Mass spectrometry-based Cellular Thermal Shift Assay (CETSA®) for target deconvolution in phenotypic drug discovery Tomas Friman · Bioorganic & Medicinal Chemistry 2 Nov 2019 66
10 Determining direct binders of the Androgen Receptor using a high-throughput Cellular Thermal Shift Assay Joseph Shaw, Mathew Leveridge, Charlotta Norling et al. · Scientific Reports Open access 3 Jan 2018 59
11 Crystal structures of SAMHD1 inhibitor complexes reveal the mechanism of water-mediated dNTP hydrolysis Elizabeth R. Morris, Sarah J. Caswell, Simone Kunzelmann et al. · Nature Communications Open access 23 Jun 2020 49
12 Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP1 Joseph Shaw, Ian L. Dale, PAUL E. HEMSLEY et al. · SLAS DISCOVERY Open access 13 Dec 2018 49
13 CETSA: A Target Engagement Assay with Potential to Transform Drug Discovery Annika Jenmalm Jensen, Daniel Martinez Molina, Thomas Lundbäck · Future Medicinal Chemistry Jun 2015 47
14 Cyclic 5-membered disulfides are not selective substrates of thioredoxin reductase, but are opened nonspecifically Jan G. Felber, Lena Poczka, Karoline Scholzen et al. · Nature Communications Open access Apr 2022 44
15 Proteome-wide cellular thermal shift assay reveals unexpected cross-talk between brassinosteroid and auxin signaling Qing Lu, Yonghong Zhang, Joakim Hellner et al. · Proceedings of the National Academy of Sciences Open access 7 Mar 2022 37
16 A Tale of Two Tails: Efficient Profiling of Protein Degraders by Specific Functional and Target Engagement Readouts Alexey L. Chernobrovkin, Cindy Cázares-Körner, Tomas Friman et al. · SLAS DISCOVERY Open access 15 Jan 2021 31
17 Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A Lars Wortmann et al. · Journal of Medicinal Chemistry Open access 26 Oct 2021 27
18 Abnormal (Hydroxy)proline Deuterium Content Redefines Hydrogen Chemical Mass Hassan Gharibi, Alexey L. Chernobrovkin, Gunilla M. Eriksson et al. · Journal of the American Chemical Society Open access 2 Feb 2022 25
19 CETSA MS Profiling for a Comparative Assessment of FDA-Approved Antivirals Repurposed for COVID-19 Therapy Identifies TRIP13 as a Remdesivir Off-Target Tomas Friman, Alexey L. Chernobrovkin, Daniel Martinez Molina et al. · SLAS DISCOVERY Open access 19 Nov 2020 24
20 Generation and validation of recombinant antibodies to study human aminoacyl-tRNA synthetases Charlotta Preger, Edvard Wigren, Elena Ossipova et al. · Journal of Biological Chemistry Open access 14 Aug 2020 22
21 On the Relationship between Molecular Hit Rates in High-Throughput Screening and Molecular Descriptors Mari Hansson, John Stuart Pemberton, Ola Engkvist et al. · SLAS DISCOVERY Open access 24 Aug 2013 20
22 Deciphering the Allosteric Binding Mechanism of the Human Tropomyosin Receptor Kinase A (hTrkA) Inhibitors Govindan Subramanian, Paul D. Johnson, Theresa Zachary et al. · ACS Chemical Biology 6 May 2019 17
23 Proteomics-Compatible Fourier Transform Isotopic Ratio Mass Spectrometry of Polypeptides Hassan Gharibi, Alexey L. Chernobrovkin, Amir Ata Saei et al. · Analytical Chemistry Open access 17 Oct 2022 16
24 A Shift in Thinking: Cellular Thermal Shift Assay-Enabled Drug Discovery Isabel Martín Caballero, Stina Lundgren · ACS Medicinal Chemistry Letters Open access 17 Mar 2023 15
25 High throughput screening of 0.5 million compounds against CRAF using Alpha CETSAⓇ Hannah Rowlands, Kirsten Tschapalda, Carolyn Blackett et al. · SLAS DISCOVERY Open access Feb 2023 15
26 Mechanistic Insights into a CDK9 Inhibitor Via Orthogonal Proteomics Methods J. Adam Hendricks et al. · ACS Chemical Biology Open access 25 Dec 2021 14
27 Inverse agonism of lysophospholipids with cationic head groups at Gi-coupled receptor GPR82 Daisuke Yasuda, Fumie Hamano, Kazuyuki Masuda et al. · European Journal of Pharmacology Open access 29 Jun 2023 10
28 In-depth characterization of Staurosporine induced proteome thermal stability changes Alexey L. Chernobrovkin, Johan Lengqvist, Cindy Körner et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 15 Mar 2020 10
29 Positive Modulation of the Glycine Receptor by Means of Glycine Receptor–Binding Aptamers Nancy Dekki Shalaly, Eduardo Aneiros, Michael Blank et al. · SLAS DISCOVERY Open access 12 Jun 2015 10
30 Discovery of 3-Amino-1H-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE Family Jennifer Alisa Amrhein, Lena M. Berger, Amelie Tjaden et al. · International Journal of Molecular Sciences Open access 27 Nov 2022 9
31 Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnel Si Min Zhang et al. · iScience Open access 19 Jan 2024 8
32 Extending in Silico Protein Target Prediction Models to Include Functional Effects Lewis Mervin, Avid M. Afzal, Lars Brive et al. · Frontiers in Pharmacology Open access 11 Jun 2018 8
33 System-wide identification and prioritization of enzyme substrates by thermal analysis (SIESTA) Amir Ata Saei, Christian M. Beusch, Pierre Sabatier et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 21 Sep 2018 6
34 Neuroprotective and Disease Modifying Effects of the Triazinetrione ACD856, a Positive Allosteric Modulator of Trk-Receptors for the Treatment of Cognitive Dysfunction in Alzheimer’s Disease Cristina Parrado‐Fernández, Sanja Juric, Maria Backlund et al. · Preprints.org PreprintOpen access 8 Jun 2023 5
35 Development of pyrazolo[1,5-a]pyrimidine based macrocyclic kinase inhibitors targeting AAK1 Theresa Elisabeth Mensing, Christian Georg Kurz, Jennifer Alisa Amrhein et al. · European Journal of Medicinal Chemistry Open access 22 Aug 2025 4
36 ProTargetMiner: A proteome signature library of anticancer molecules for functional discovery Amir Ata Saei, Alexey L. Chernobrovkin, Pierre Sabatier et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 18 Sep 2018 4
37 Phenomics‐Based Discovery of Novel Orthosteric Choline Kinase Inhibitors Ludwig G. Bauer et al. · Angewandte Chemie International Edition Open access 30 Dec 2024 2
38 Discovery of RNA-Protein Molecular Clamps Using Proteome-Wide Stability Assays Stanley I. Goldstein, Alice C. Fan, Zihao Wang et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 19 Apr 2024 2
39 A mass spectrometry‐based non‐radioactive differential radial capillary action of ligand assay (DRaCALA) to assess ligand binding to proteins Annika Cimdins, Alexey L. Chernobrovkin, Sookyoung Kim et al. · Journal of Mass Spectrometry Open access 14 Mar 2022 2
40 Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralising SARS-CoV-2 nanobodies Leo Hanke, Daniel J. Sheward, Alec P. Pankow et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 26 Jul 2021 2
41 SIESTA as a universal unbiased proteomics approach for identification and prioritization of enzyme substrates Amir Ata Saei, Christian Michel Beusch, Pierre Sabatier et al. · Research Square PreprintOpen access 26 Feb 2021 2
42 Quantitative target engagement of RIPK1 in human whole blood via the cellular thermal shift assay for potential pre-clinical and clinical applications Shitalben Patel, Marie Karlsson, Joseph T. Klahn et al. · SLAS DISCOVERY Open access 13 Dec 2023 1
43 Morphological and Mechanistic Aspects of Thiourea-Induced Acute Lung Injury and Tolerance in the Rat Giovanni Pellegrini, Dominic P. Williams, Daniele Amadio et al. · Toxicologic Pathology Open access Aug 2020 1
44 Toward a Species Search Engine: KISSE Offers a Rigorous Statistical Framework for Bone Collagen Tandem Mass Spectrometry Data Hassan Gharibi, Amir Ata Saei, Alexey L. Chernobrovkin et al. · Advanced Science Open access 11 Aug 2025 0
45 Role of Structural Modifications in Peptidomimetic Compounds as Potential Antimicrobial Agents against Staphylococcus aureus and Streptococcus pyogenes: Balancing Bioavailability, Safety, and Antimicrobial Activity Maria Dzierżyńska, Justyna Sawicka, Katarzyna Łada et al. · ACS Omega Open access 22 Jul 2025 0
46 CETSA-MS unveils novel targets engaged by rigosertib to promote anti-tumor activity and inflammatory responses Petros Kechagioglou, Hajime Yurugi, Camille Amandine Dupont et al. · iScience Open access 26 May 2025 0
47 Towards a species search engine: KISSE offers a rigorous statistical framework for bone collagen tandem mass spectrometry data Hassan Gharibi, Amir Ata Saei, Alexey L. Chernobrovkin et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 26 Mar 2025 0
48 Phänomik‐basierte Entdeckung neuer orthosterischer Cholinkinase Inhibitoren Ludwig G. Bauer et al. · Angewandte Chemie Open access 30 Dec 2024 0
49 Exploring the Limits of High-Density Perimetry for Characterizing Mild Defects Iván Marín‐Franch, Harry J. Wyatt, William H. Swanson · SSRN Electronic Journal PreprintOpen access 2022 0
50 Proteome-wide cellular thermal shift assay reveals novel crosstalk between brassinosteroid and auxin signaling Qing Lu, Yonghong Zhang, Joakim Hellner et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 16 Dec 2021 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.